World map showing global connections between multiple locations. News |

US loses measles elimination status – what does this mean for Australia?

On 17 November, the Pan American Health Organization (PAHO), the regional office of the World Health Organization (WHO) for the Americas, confirmed that the United States (US) has formally lost its measles elimination status, reversing a public health milestone maintained since 2000. 

The decision follows a review by PAHO’s Regional Monitoring and Re-Verification Commission, an independent expert body, which found that a single measles virus lineage had circulated continuously without a break in the US for 12 months or more, meaning the virus is once again endemic to the country. 

While measles remains eliminated in Australia, the US setback highlights how rapidly declining vaccination coverage, growing immunity gaps, misinformation and global travel can erode decades of disease control. 

‘This is a reminder that measles elimination status cannot be taken for granted. Achieving and maintaining it requires ongoing effort,’ said NCIRS Interim Director Professor Nicholas Wood.

‘Some of the factors that contributed to the US losing its status, including declining vaccination coverage and growing immunity gaps, are also present in Australia.’
 

What does losing measles elimination status mean?

Measles elimination means there is no ongoing, home-grown transmission of the virus within the community, although imported cases may still occur. 

When travellers bring measles into a country where it has been eliminated, strong population immunity through high vaccination coverage, combined with rapid contact tracing, usually prevent further spread. This is the case in Australia, where imported measles cases occur, particularly during peak travel periods such as the summer months, but do not result in ongoing local spread.

Elimination status is lost when epidemiological and laboratory evidence shows transmission of the same measles virus lineage (genetically related viruses) has continued uninterrupted for 12 months or more in a country where measles had been eliminated. This indicates that measles has become re-established rather than remaining limited to imported cases.
 

Why did the US lose its measles elimination status?

Measles outbreaks generally do not begin because the virus changes. They occur when population protection changes.

Measles is one of the world’s most contagious viruses. A person with measles can infect up to 90% of unprotected close contacts. Preventing sustained outbreaks requires at least 95% 2-dose vaccination coverage across communities, helping to protect people who cannot be vaccinated, including young babies.

For decades, high population immunity in the US meant that imported measles cases were quickly contained and did not lead to sustained outbreaks. However, in recent years, measles-mumps-rubella (MMR) vaccination coverage among kindergarteners in the US has fallen below 95%, declining from 95.2% in 2019–20 to 92.4% in 2025–26 and leaving about 280,000 kindergartners at risk. While national averages can look reassuring, much lower coverage in some communities now allows imported cases to keep spreading.

Following sustained outbreaks that began in early 2025, the US recorded more than 5,400 confirmed cases in 2026 alone, the highest annual tally since 1991. That is more cases in under 2 years than in the previous 25 years combined. Genetic sequencing showed that outbreaks in Utah and Arizona belong to the same virus lineage as the West Texas outbreak and were still spreading more than a year later.

US state health departments have reported 10 measles-associated deaths in 2026, including infants too young to be vaccinated. The US Centers for Disease Control and Prevention (CDC) national tally, which is still under review, lists 6 deaths. Together with 3 deaths in 2025, that is more than the previous 25 years combined. 

CDC data show that 96% of reported measles cases in 2026 occurred in people whose vaccination status was unvaccinated or unknown, underscoring the heavy toll of measles infection on unprotected communities.

The resurgence has also unfolded amid significant changes to US vaccine policy. This has included the removal of all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) in June 2025 and an August 2026 executive order calling for the MMR vaccine to be given as 3 separate vaccines once available. The CDC states that there is no published scientific evidence to support any benefit from separating out the MMR vaccine. 

Researchers have also identified [PDF] misinformation, declining vaccine confidence and growing immunity gaps as key factors that have allowed outbreaks to persist.

‘The US did not lose elimination status overnight. A decline of just a few percentage points in coverage over several years, combined with increased international travel and the accumulation of unvaccinated or incompletely vaccinated people, was enough to unravel decades of population protection,’ said Professor Wood.
 

What does this mean for the US and the world?

Officially, little changes. The CDC says its outbreak response will stay the same. But the loss is a warning.

The US experience shows how quickly a seemingly small decline in vaccination coverage can reverse years of progress. Measles is often seen as a barometer for wider immunisation programs: whooping cough, for example, has also resurged in the US since 2024.

The US is not alone. Seven countries, including Canada, Spain and the United Kingdom, have lost elimination status in the past 2 years, and Bolivia and Mexico, reviewed at the same PAHO meeting, officially lost their status alongside the US on 17 November 2026.
 

How can a country regain elimination status?

Losing elimination status is reversible, though recovery requires sustained public health action. 

Brazil lost its measles elimination status in 2019 before successfully regaining it in 2024 after strengthening vaccination, surveillance and outbreak response, and Venezuela regained its status in 2023 after an outbreak that began in 2018 – a reminder that recovery takes years.

Regaining official elimination status will require stopping all local chains of transmission for at least 12 consecutive months, alongside higher routine MMR vaccination coverage, fewer immunity gaps for the virus to hop between communities, and strong disease surveillance.

The pathway back is well understood. The challenge is not a lack of scientific tools or evidence, but sustaining the effort and investment needed to restore and maintain high levels of community protection.
 

What does this mean for Australia?

Australia has maintained WHO-verified measles elimination status since 2014, which was reaffirmed by the WHO Western Pacific Regional Verification Commission in September 2026. The Commission noted that the recent sharp rise in cases recorded in Australia reflects importations during the global measles resurgence rather than sustained local transmission. 

Despite retaining its measles elimination status, Australia faces several emerging risk factors for imported cases and local outbreaks:

  • Cases are rising: Notifications increased from 57 measles cases in 2024 to 181 in 2025, more than tripling in a single year. Most are linked to overseas travel, the main way measles reaches Australia, but some locally acquired cases have had no known source, which can signal undetected local spread.
  • Immunity gaps are widening: A recent NCIRS-led study identified immunity gaps across multiple generations of Australians, with an estimated 1.7 million people susceptible (lacking sufficient immunity) to measles in 2019. Significant gaps were seen among some adults born from the late 1970s onwards and children too young to be vaccinated. Gaps are likely to be larger in some communities and regions.
  • Coverage is declining: National AIR data show MMR coverage for 2-year-olds fell from 94.1% in 2020 to 90.0% in 2026, dropping further below the 95% coverage level required to prevent sustained measles transmission. 

Rising global measles activity and declining vaccination coverage in Australia increase the risk of imported cases and local outbreaks. 

‘With measles circulating in many parts of the world and most Australian cases linked to overseas travel, maintaining our elimination status will require public confidence in immunisation, re-establishing high vaccination coverage and maintaining strong surveillance,' said Professor Wood.
 

How can Australians stay protected?

Two doses of a measles-containing vaccine are up to 99% effective in preventing measles. Protecting yourself also helps protect babies who are too young to be vaccinated. Australians should check their vaccination status, particularly those planning overseas travel. To help prepare:

  • Check your immunisation history: Anyone born during or since 1966 should have 2 documented doses of a measles-containing vaccine (given at least 4 weeks apart from 12 months of age) or other evidence of immunity, such as a blood test. You can check your records on the Australian Immunisation Register or ask your healthcare provider.
  • Get a free catch-up vaccination if unsure: If you have missed a dose or cannot confirm your vaccination record, speak to your healthcare or immunisation provider. Extra doses are safe, and catch-up MMR vaccination is free for eligible people through the National Immunisation Program (NIP) and state and territory programs.
  • Plan ahead for travel: See your healthcare provider at least 6 to 8 weeks before you leave to allow enough time to build full immunity, especially if you need 2 doses, spaced 4 weeks apart.
  • Consider early vaccination for infants travelling overseas: Infants aged 6 to 11 months travelling overseas may be eligible for a funded early dose of MMR vaccine before departure, following an individual risk assessment (they will still require their routine doses at 12 and 18 months).
     

Learn more at our upcoming webinar

NCIRS will explore these issues in more detail during its upcoming webinar, What's new in travel vaccination – dengue, rabies and measles, on Tuesday 1 December, 12:00–1:00 pm AEDT. The session will cover rising measles activity in Australia and globally, measles susceptibility among Australians, and vaccination recommendations for overseas travellers. 

Register for the webinar
 

Further resources